Key Movers to Look for Ahead of ASCO
The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers will share the results from their most recent drug trials.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 211
8 Speculative Biotech and Biohealth Stocks With Major Analyst Upside Calls
Here are seven speculative biotech and biohealth players in which analyst calls during the week ending May 27 have given major upside projections.
Why Titan Pharmaceuticals Shares Are Rising
Shares of Titan Pharmaceuticals saw a handy gain early in Friday’s session following the U.S. Food and Drug Administration (FDA) approval of its partner’s opioid dependence treatment.
Thermo Fisher Pays $4.2 Billion for Microscope Maker
Thermo Fisher Scientific said Friday morning that it has agreed to acquire FEI for approximately $4.2 billion in cash.
Analyst Has 2 Biotech Stocks to Buy With at Least 100% Upside Potential
These two biotech companies not only have data that could prove to be huge, but the stocks have been absolutely hammered over the past year, offering the best entry points in some time.
Why Minerva’s Incredible Move May Be Justified
Minerva Neurosciences saw its shares make absolutely massive gains on Thursday following the release of positive results from a couple mid-stage clinical trials.
Ionis Pharmaceuticals Drops on Dismissed Study
Ionis Pharmaceuticals shares dropped severely after a less-than positive update on its IONIS-TTR Rx program.
How Medivation Shareholders May Lose Big by Poison Pill in Hostile Takeover Fight With Sanofi
Usually the term "hostile takeover" is an exaggeration, but Sanofi's takeover bid for Medivation actually looks pretty hostile, given that it is now trying to oust the entire board.
OvaScience Prices Secondary Offering
OvaScience shares dropped early on Thursday after the company announced that it had priced its secondary offering of more than 7 million shares at $7 per share.
Capital Infusions Are More Evidence of a Biotech Turnaround
Here are four biotech companies that have just either closed fresh financing rounds or issued IPOs that exceeded price expectations.
7 Companies in the Fight to Defeat the Zika Virus
Many companies are being discussed as Zika virus winners, but the reality is that many of them are so small or have sketchy histories. This is why we are featuring seven notable companies targeting…
Why Sarepta’s PDUFA Delay Is a Good Thing
Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares saw a handy gain on Wednesday following an analyst upgrade from Janney Montgomery Scott.
Cellectar Wins Big on New Patent
Cellectar Biosciences watched its shares skyrocket on Wednesday morning following the announcement that it has obtained a patent that covers CLR 1603, a phospholipid ether-paclitaxel.
4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends
Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue to stay around.
5 Major Clinical Trial Results Coming Up
24/7 Wall St. has collected several big FDA decisions and imminent clinical trial results that should be coming up in the June quarter. We have added some color.